Title: Open-label feasibility study of pazopanib, carboplatin, and paclitaxel in women with newly diagnosed, untreated, gynaecologic tumours: a phase I/II trial of the AGO study group
Authors: du Bois, A ×
Vergote, Ignace
Wimberger, P
Ray-Coquard, I
Harter, P
Curtis, L. B
Mitrica, I #
Issue Date: Feb-2012
Publisher: Harcourt Publishers
Series Title: British Journal of Cancer vol:106 issue:4 pages:629-632
Article number: 10.1038/bjc.2011.608
Abstract: Although most patients with advanced gynaecologic malignancies respond to first-line treatment with platinum-taxane doublets, a significant proportion of patients relapse. Combining targeted agents that have non-overlapping mechanisms of action with chemotherapy may potentially increase the disease-free interval. Accordingly, this study evaluated the feasibility of combining pazopanib, an oral angiogenesis inhibitor, with paclitaxel and carboplatin.
ISSN: 0007-0920
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Gynaecological Oncology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science